Get started
Work

Anti-TIGIT inhibitors plus PD-1 or PD-L1 inhibitors versus PD-1 or PD-L1 inhibitors for first-line treatment of advanced non-small cell lung cancer

Year: 2025
Type: article
Study design: Study Protocol
Abstract: OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the effectiveness and safety of anti-TIGIT inhibitors in combination with PD-1 inhibitors or PD-L1 inhibitors compared to treatment with PD-1 inhibitors or PD-L1 inhibitors in the first-line treatment of advanced NSCLC. To assess the effectiveness and safety of anti-TIGIT inhibitors in combination with chemotherapy and PD-1 inhibitors or PD-L1 inhibitors compared to treatment with chemotherapy plus PD-1 inhibitors or PD-L1 inhibitors in the first-line treatment of advanced NSCLC.
DOI: 10.1002/14651858.cd015888
Authors: Ming Liu, Ya Gao, Lun Li, Long Ge, Liang Yao, Xiajing Chu, Fanqi Wu, Jinhui Tian
Institutions: Lanzhou University, Shandong University, Central South University, Second Xiangya Hospital of Central South University, Xiangya Hospital Central South University, Nanyang Technological University, McMaster University, Lanzhou University Second Hospital
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W4409410713
FWCI:
Cites: 27
Cited by:
Related to: 10